Ensysce Biosciences (ENSCW) Accumulated Expenses (2017 - 2021)

Ensysce Biosciences (ENSCW) has 4 years of Accumulated Expenses data on file, last reported at $411941.0 in Q2 2021.

• Accumulated Expenses for Q2 2021 came in at $411941.0, changed N/A year-over-year; the trailing twelve-month figure through Jun 2021 was $411941.0 (changed N/A YoY), and the FY2020 annual result was $52807.0, changed N/A from the prior year.
• Accumulated Expenses grew to $411941.0 in Q2 2021 per ENSCW's latest filing, from $52807.0 in the prior quarter.
• Over five years, Accumulated Expenses peaked at $411941.0 in Q2 2021 and troughed at $8640.0 in Q1 2018.
• A 4-year average of $77135.4 and a median of $8640.0 in 2018 frame the typical range for Accumulated Expenses.
• On a YoY basis, Accumulated Expenses climbed as much as 78.74% in 2018 and fell as far as 78.74% in 2018.
• A 4-year view of Accumulated Expenses shows it stood at $40640.0 in 2017, then sank by 78.74% to $8640.0 in 2018, then soared by 511.19% to $52807.0 in 2020, then jumped by 680.09% to $411941.0 in 2021.
• Business Quant data shows ENSCW's Accumulated Expenses at $411941.0 in Q2 2021, $52807.0 in Q4 2020, and $8640.0 in Q4 2018.